Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-Analysis

RATIONALE AND OBJECTIVE: Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy (renin-angiotensin-aldosterone system [RAAS] inhibitor) to control proteinuria in primary and genetic focal segmental glomerulosclerosis (FSGS) follows guidelines based on other proteinuria-relat...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Kirk N., Pennese, Natali, Zaffalon, Andrea, Magalhaes, Barbara, Faiella, Marina, Caster, Dawn J., Radhakrishnan, Jai, Tesar, Vladimir, Trachtman, Howard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065901/
https://www.ncbi.nlm.nih.gov/pubmed/35518835
http://dx.doi.org/10.1016/j.xkme.2022.100457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065901/
https://www.ncbi.nlm.nih.gov/pubmed/35518835
http://dx.doi.org/10.1016/j.xkme.2022.100457

Ejemplares similares